Grenoble, France

Alexis Broisat

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Grenoble, Université Grenoble Alpes, Virje Universiteit Brussel. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Alexis Broisat in Medical Imaging

Introduction

Alexis Broisat is a notable inventor based in Grenoble, France. He has made significant contributions to the field of medical imaging through his innovative work on nanobodies. His research focuses on developing solutions that enhance diagnostic and treatment methods.

Latest Patents

One of his key patents is titled "Anti-VCAM-1 nanobodies." This invention relates to nanobodies specifically directed against VCAM-1 and their applications in medical imaging, as well as in diagnostic, prognostic, and treatment methods. He holds 1 patent in this area, showcasing his expertise and commitment to advancing medical technology.

Career Highlights

Throughout his career, Alexis Broisat has worked with esteemed institutions such as Vrije Universiteit Brussel and Centre Hospitalier Universitaire de Grenoble. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Catherine Ghezzi and Daniel Fagret. Their collective efforts have furthered the understanding and application of nanobodies in medical science.

Conclusion

Alexis Broisat's innovative work in the development of anti-VCAM-1 nanobodies represents a significant advancement in medical imaging and treatment methodologies. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…